Our people have broad clinical and medical expertise that encompasses the whole spectrum of drug discovery and development including proof of principle studies, Phase l and Phase ll studies, Phase lll pivotal trials, compassionate drug use and Phase lV programmes.

We have conducted over 70 clinical trials in 20 countries worldwide in therapeutic areas such as oncology, cardiovascular, endocrinology, immunology, neurology and infectious diseases.